0001127602-15-033057.txt : 20151202
0001127602-15-033057.hdr.sgml : 20151202
20151202182020
ACCESSION NUMBER: 0001127602-15-033057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151201
FILED AS OF DATE: 20151202
DATE AS OF CHANGE: 20151202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stejbach Mark
CENTRAL INDEX KEY: 0001487937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 151265852
MAIL ADDRESS:
STREET 1: C/O TENGION, INC.
STREET 2: 2900 POTSHOP LANE, SUITE 100
CITY: EAST NORRITON
STATE: PA
ZIP: 19403
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-12-01
0001520262
Alkermes plc.
ALKS
0001487937
Stejbach Mark
852 WINTER ST.
WALTHAM
MA
02451
1
Chief Commercial Officer
Ordinary Shares
2015-12-01
4
M
0
18000
17.30
A
37564
D
Ordinary Shares
2015-12-01
4
S
0
15200
71.9943
D
22364
D
Ordinary Shares
2015-12-01
4
S
0
2300
73.0891
D
20064
D
Ordinary Shares
2015-12-01
4
S
0
500
73.582
D
19564
D
Employee Stock Option (Right to Buy)
17.30
2015-12-01
4
M
0
18000
0
D
2013-03-07
2022-03-07
Ordinary Shares
18000
52440
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.39 to $72.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.47 to $73.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.48 to $73.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 3/7/13.
/s/ Jennifer Baptiste, attorney-in-fact for Mark Stejbach
2015-12-02